Squamous Cell Carcinoma of the Penis, Usual Type
Oncology·MeSH: Penile Neoplasms
Prevalence
0.5 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Ifosfamide | UNITED THERAPEUTICS Corp (UTHR) |
Frequently asked questions
How many drugs are in development for Squamous Cell Carcinoma of the Penis, Usual Type?
BioSniper tracks 1 drug in development for Squamous Cell Carcinoma of the Penis, Usual Type across 1 company.
How many clinical trials target Squamous Cell Carcinoma of the Penis, Usual Type?
There are 1 clinical trial targeting Squamous Cell Carcinoma of the Penis, Usual Type tracked by BioSniper.
What is the prevalence of Squamous Cell Carcinoma of the Penis, Usual Type?
The estimated prevalence of Squamous Cell Carcinoma of the Penis, Usual Type is approximately 0.5 per 100,000 population.
Deep-dive into Squamous Cell Carcinoma of the Penis, Usual Type
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis